Clinical Trial Update: Cannabinol Use in Patients With Insomnia Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on cannabinol use for insomnia disorder is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• Cannabinol (cannabinol)

Snippet

Sponsor: Woolcock Institute of Medical Research | Conditions: Insomnia Disorder | Phase 1, Phase 2 | Status: COMPLETED